TCS partners with medical research technology firm QIAGEN for digital transformation

TCS partners with medical research technology firm QIAGEN for digital transformation
Photo Credit: 123RF.com
26 Feb, 2020

Mumbai-based information technology services firm Tata Consultancy Services (TCS) has signed a digital transformation deal with German medical technology research firm QIAGEN. 

Under the partnership, TCS helps the Germany-based firm’s genomics division’s global biology and biomedical research platform improve its user experience with new digital capabilities, increase customer engagement and provide a better user experience with the re-architected collaboration platform GeneGlobe Design and Analysis Hub.

QIAGEN is a provider of sample-to-insight solutions for customers in the life sciences and molecular diagnostics sectors. The company said that while it is catering to the expectations of a large proportion of researchers who are digital natives, it is also looking to transform its GeneGlobe research platform.

“With GeneGlobe, we are offering researchers one place to navigate knowledge, tools and analyses for their specific target, saving researchers time and budget,” Peter Rene Hesse, head of digitalisation at QIAGEN life sciences business, said.

TCS said that its deep contextual knowledge, strong digital capabilities in cloud and microservices, as well as expertise in designing intuitive, customer-centric platforms has helped QIAGEN to meet its expectations from the deal.

The country’s largest software exporter TCS adopted a cloud-based microservices architecture and revamped the GeneGlobe platform by leveraging industry-best DevOps practices and design thinking approaches, it said in the statement.

“With the new intuitive, customer-centric design and scalable cloud-native architecture, QIAGEN’s platform delivers a superior user experience that will attract a new class of researchers, and accelerate and spur new research that improves lives,” Vikas Jain, business head for life sciences at TCS, said.  

TCS said that its algorithms link products to biological targets so researchers could explore and expedite decisions on products within the relevant context. It also provides personalised dashboards and product builders that are easy to use while enabling the creation of virtually any custom product for a specific research question. This has, in turn, helped QIAGEN boost its overall digital revenue, the company said.

Last week, TCS signed a deal with Saudi Arabia’s Banque Saudi Fransi to deploy its TCS BaNCS platform, a software-as-a service-based integrated suite that helps banks and financial companies with digital transformation. 

Earlier this month, Swedish grocery retailer Coop Sweden signed on TCS for its digital transformation to help the retailer provide consistent consumer experiences across its digital platforms.